NAS:CARA (USA)   Healthcare » Biotechnology
Cara Therapeutics Inc logo

Cara Therapeutics Inc $ 13.20 0.32 (2.48%)

Volume:
484,219
Avg Vol (1m):
1,642,403
Market Cap $:
660.69 Mil
Enterprise Value $:
493.99 Mil
PE Ratio:
40.01
PB Ratio:
2.90
Warning! GuruFocus has detected 1 Severe warning sign with CARA. Click here to check it out.
Also Trade In: Germany UK
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

CARA Stock Institutional Ownership and Insider Ownership - Cara Therapeutics Inc

50.05
(Mil)
Shares Outstanding
55.12%
27.49 (Mil)
Institutional Ownership
3.38%
1.69 (Mil)
Insider Ownership
98.04%
49.0714 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Cara Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of Cara Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders